PortfoliosLab logo
IESC vs. RVPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IESC and RVPH is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

IESC vs. RVPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IES Holdings, Inc. (IESC) and Reviva Pharmaceuticals Holdings, Inc. (RVPH). The values are adjusted to include any dividend payments, if applicable.

0.00%500.00%1,000.00%1,500.00%NovemberDecember2025FebruaryMarchApril
1,022.63%
-91.14%
IESC
RVPH

Key characteristics

Sharpe Ratio

IESC:

0.78

RVPH:

-0.53

Sortino Ratio

IESC:

1.45

RVPH:

-0.34

Omega Ratio

IESC:

1.19

RVPH:

0.96

Calmar Ratio

IESC:

0.84

RVPH:

-0.75

Martin Ratio

IESC:

2.33

RVPH:

-1.21

Ulcer Index

IESC:

24.83%

RVPH:

59.41%

Daily Std Dev

IESC:

73.93%

RVPH:

137.11%

Max Drawdown

IESC:

-99.54%

RVPH:

-95.54%

Current Drawdown

IESC:

-50.39%

RVPH:

-92.76%

Fundamentals

Market Cap

IESC:

$4.03B

RVPH:

$42.07M

EPS

IESC:

$10.73

RVPH:

-$0.90

PS Ratio

IESC:

1.34

RVPH:

0.00

PB Ratio

IESC:

6.18

RVPH:

49.19

Total Revenue (TTM)

IESC:

$2.29B

RVPH:

$0.00

EBITDA (TTM)

IESC:

$275.99M

RVPH:

-$14.10M

Returns By Period

In the year-to-date period, IESC achieves a 0.22% return, which is significantly higher than RVPH's -52.49% return.


IESC

YTD

0.22%

1M

20.84%

6M

-3.17%

1Y

53.61%

5Y*

60.50%

10Y*

37.87%

RVPH

YTD

-52.49%

1M

-14.85%

6M

-24.56%

1Y

-71.24%

5Y*

-39.62%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IESC vs. RVPH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IESC
The Risk-Adjusted Performance Rank of IESC is 7878
Overall Rank
The Sharpe Ratio Rank of IESC is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of IESC is 7777
Sortino Ratio Rank
The Omega Ratio Rank of IESC is 7676
Omega Ratio Rank
The Calmar Ratio Rank of IESC is 8282
Calmar Ratio Rank
The Martin Ratio Rank of IESC is 7676
Martin Ratio Rank

RVPH
The Risk-Adjusted Performance Rank of RVPH is 2121
Overall Rank
The Sharpe Ratio Rank of RVPH is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of RVPH is 2828
Sortino Ratio Rank
The Omega Ratio Rank of RVPH is 2828
Omega Ratio Rank
The Calmar Ratio Rank of RVPH is 77
Calmar Ratio Rank
The Martin Ratio Rank of RVPH is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IESC vs. RVPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IES Holdings, Inc. (IESC) and Reviva Pharmaceuticals Holdings, Inc. (RVPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for IESC, currently valued at 0.78, compared to the broader market-2.00-1.000.001.002.003.00
IESC: 0.78
RVPH: -0.53
The chart of Sortino ratio for IESC, currently valued at 1.45, compared to the broader market-6.00-4.00-2.000.002.004.00
IESC: 1.45
RVPH: -0.34
The chart of Omega ratio for IESC, currently valued at 1.19, compared to the broader market0.501.001.502.00
IESC: 1.19
RVPH: 0.96
The chart of Calmar ratio for IESC, currently valued at 1.17, compared to the broader market0.001.002.003.004.005.00
IESC: 1.17
RVPH: -0.75
The chart of Martin ratio for IESC, currently valued at 2.33, compared to the broader market-5.000.005.0010.0015.0020.00
IESC: 2.33
RVPH: -1.21

The current IESC Sharpe Ratio is 0.78, which is higher than the RVPH Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of IESC and RVPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.00NovemberDecember2025FebruaryMarchApril
0.78
-0.53
IESC
RVPH

Dividends

IESC vs. RVPH - Dividend Comparison

Neither IESC nor RVPH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IESC vs. RVPH - Drawdown Comparison

The maximum IESC drawdown since its inception was -99.54%, roughly equal to the maximum RVPH drawdown of -95.54%. Use the drawdown chart below to compare losses from any high point for IESC and RVPH. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-36.32%
-92.76%
IESC
RVPH

Volatility

IESC vs. RVPH - Volatility Comparison

The current volatility for IES Holdings, Inc. (IESC) is 24.91%, while Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a volatility of 57.94%. This indicates that IESC experiences smaller price fluctuations and is considered to be less risky than RVPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%NovemberDecember2025FebruaryMarchApril
24.91%
57.94%
IESC
RVPH

Financials

IESC vs. RVPH - Financials Comparison

This section allows you to compare key financial metrics between IES Holdings, Inc. and Reviva Pharmaceuticals Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items